HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruption in the vertebral artery.

AbstractBACKGROUND AND PURPOSE:
When the clinical and radiologic characteristics of an unusual cervical spinal cord complication of intra-arterial (IA) chemotherapy with blood brain-barrier (BBB) disruption in the vertebral circulation are documented. Seven cases are reported and analyzed in search of a pathophysiologic explanation.
METHODS:
We retrospectively identified 94 patients who received a total of 380 standardized regimens of IA carboplatin, IA or IV etoposide phosphate, and IV cyclophosphamide infusion in conjunction with osmotic BBB disruption of the vertebral artery. We describe seven of those patients in whom unexpected neck pain developed followed by neurologic symptoms primarily in the upper extremities.
RESULTS:
The symptoms correlated with MR abnormalities (T1 hypointensity, T2 hyperintensity, and unusual contrast enhancement) in the cervical spinal cord, usually involving the gray matter. The neurologic deficits and MR changes were generally transient. One patient who received a flu vaccination 48 hours before the chemotherapy incurred progressive myelitis and expired.
CONCLUSION:
The pathophysiology of this complication is probably multifactorial but may be related to vascular streaming and an atypical inflammatory toxic reaction to carboplatin and etoposide. The complication has not recurred during a 6-month period following modification of the protocol.
AuthorsD Fortin, L D McAllister, G Nesbit, N D Doolittle, M Miner, E J Hanson, E A Neuwelt
JournalAJNR. American journal of neuroradiology (AJNR Am J Neuroradiol) 1999 Nov-Dec Vol. 20 Issue 10 Pg. 1794-802 ISSN: 0195-6108 [Print] United States
PMID10588099 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Influenza Vaccines
  • Mannitol
  • Etoposide
  • Cyclophosphamide
  • Carboplatin
Topics
  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects)
  • Blood-Brain Barrier (drug effects)
  • Brain Neoplasms (drug therapy, pathology)
  • Carboplatin (administration & dosage, adverse effects)
  • Cervical Vertebrae (pathology)
  • Cyclophosphamide (administration & dosage, adverse effects)
  • Etoposide (administration & dosage, adverse effects)
  • Female
  • Humans
  • Influenza Vaccines (adverse effects)
  • Infusions, Intra-Arterial
  • Infusions, Intravenous
  • Magnetic Resonance Imaging
  • Male
  • Mannitol (adverse effects)
  • Middle Aged
  • Myelitis (chemically induced, diagnosis)
  • Neurologic Examination (drug effects)
  • Retrospective Studies
  • Spinal Cord (drug effects, pathology)
  • Vertebral Artery (drug effects, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: